Position in ASND
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$92,169,630
-$10,168,975 QoQ
Shares Held
345,567
-22.8% QoQ
Ownership
0.527%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#28
of 308 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 96%
Shared 0%
None 4%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FIL Ltd holds $519,698,806 across 28 Biotechnology names. ASND ranks #2 (17.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
265,490 | $165,543,634 | |
| 2 | ASND |
Ascendis Pharma A/S
This page
|
345,567 | $92,169,630 | |
| 3 | INSM |
INSMED Inc
|
856,214 | $91,289,536 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
1,002,260 | $74,648,324 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
92,038 | $27,706,198 | |
| 6 | CAI |
Caris Life Sciences, Inc.
|
1,548,918 | $27,601,718 | |
| 7 | ARGX |
Argenx SE
|
16,249 | $15,075,334 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
26,508 | $13,167,318 |
All Filings in ASND
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $92,169,630 | 345,567 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $102,338,605 | 447,421 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $102,065,406 | 478,641 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $91,321,385 | 459,340 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $80,102,968 | 464,096 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $72,064,363 | 462,366 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $100,399,288 | 729,275 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $95,597,070 | 640,259 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $60,349,240 | 442,508 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $1,621,600 | 10,727 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $755,448 | 5,998 | Shares | Defined | 2024-02-13 | |
| 2023-03-31 | $4,824,900 | 45,000 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $5,503,788 | 45,065 | Shares | Defined | 2023-02-13 | |
| 2021-09-30 | $106,631 | 669 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $17,758,458 | 134,994 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $22,152,279 | 171,883 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $27,272,531 | 163,524 | Shares | Defined | 2021-03-23 | |
| 2020-09-30 | $14,647,590 | 94,917 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $14,019,884 | 94,793 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $21,617,065 | 191,964 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||